Cystic Fibrosis Therapeutics Market

The global cystic fibrosis therapeutics market grew at a CAGR of around 15% during 2014-2019. Cystic fibrosis (CF) is a rare and progressive genetic disorder that is characterized by an abnormal movement of sodium and chloride across the gastrointestinal and respiratory tracts. This disorder can cause the development of viscous secretions in the lungs, pancreas, intestines and liver. The management and treatment of CF involve physical therapy, gene therapy, physiotherapy and nutritional support. Along with this, gene therapy and medicinal drugs, such as pancreatic enzyme supplements, mucolytics, bronchodilators and cystic fibrosis transmembrane conductance regulator (CFTR) modulators are also used for targeting cellular interactomes and symptomatic improvement. These drugs can be administered to the patient orally or by inhalation.

The rising incidence of cystic fibrosis across the globe, along with improvements in the diagnostic technologies of the disorder, is one of the key factors driving the growth of the market. Furthermore, widespread adoption of cystic fibrosis transmembrane conductance (CFTR) modulators as a treatment alternative is also providing a boost to the market growth. CFTRs are configured to regulate the flow of water and chloride through cell linings of the lungs and other organs and correct the malfunctioning protein in the body. Additionally, various technological advancements, such as the development of personalized drug therapy, molecular prosthetics and innovative drugs with improved efficacy, are acting as another growth-inducing factor. Other factors, including rising healthcare expenditures, increasing health consciousness, and awareness regarding the available treatment options for cystic fibrosis, are projected to drive the market further. Looking forward, IMARC Group expects the global cystic fibrosis therapeutics market to continue to exhibit strong growth during 2020-2025.

Breakup by Drug Class:

• Pancreatic Enzyme Supplements
• Mucolytics
• Bronchodilators
• CFTR Modulators
• Antibiotics
• Others
   

Breakup by Drug Molecule Type:

• Small Molecule Drugs
• Biologics
   

Breakup by Route of Administration:

• Oral Drugs
• Inhaled Drugs
   

Breakup by End-User:

• Hospitals
• Clinics
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Alaxia, Alcresta Therapeutics Inc., Allergan, AstraZeneca, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., etc.

Key Questions Answered in This Report:

• How has the global cystic fibrosis therapeutics market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global cystic fibrosis therapeutics market?
• What is the breakup of the market based on the drug class?
• What is the breakup of the market based on the drug molecule type?
• What is the breakup of the market based on the route of administration?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global cystic fibrosis therapeutics market and who are the key players?
• What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Cystic Fibrosis Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Imapct of COVID-19    
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Pancreatic Enzyme Supplements
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Mucolytics
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Bronchodilators
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    CFTR Modulators
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Antibiotics
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Drug Molecule Type
    7.1    Small Molecule Drugs
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Biologics
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Route of Administration
    8.1    Oral Drugs
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Inhaled Drugs
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by End-User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Clinics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Indicators
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbvie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Alaxia
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Alcresta Therapeutics Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
        15.3.4    Allergan
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials 
           15.3.4.4 SWOT Analysis
        15.3.5    AstraZeneca
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials 
           15.3.5.4 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche Ltd
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Gilead Sciences Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials 
           15.3.7.4 SWOT Analysis
        15.3.8    Merck & Co., Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials 
           15.3.8.4 SWOT Analysis
        15.3.9    Novartis AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials 
           15.3.9.4 SWOT Analysis
        15.3.10    Teva Pharmaceutical Industries Ltd.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials 
           15.3.10.4 SWOT Analysis
        15.3.11    Vertex Pharmaceuticals Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials 
           15.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Cystic Fibrosis Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Cystic Fibrosis Therapeutics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Class (in %), 2019
Figure 4: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Molecule Type (in %), 2019
Figure 5: Global: Cystic Fibrosis Therapeutics Market: Breakup by Route of Administration (in %), 2019
Figure 6: Global: Cystic Fibrosis Therapeutics Market: Breakup by End-User (in %), 2019
Figure 7: Global: Cystic Fibrosis Therapeutics Market: Breakup by Region (in %), 2019
Figure 8: Global: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 9: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Cystic Fibrosis Therapeutics (Biologics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Cystic Fibrosis Therapeutics (Biologics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Cystic Fibrosis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Cystic Fibrosis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Cystic Fibrosis Therapeutics (Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Cystic Fibrosis Therapeutics (Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: North America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: North America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: United States: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: United States: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Canada: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Canada: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Asia Pacific: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Asia Pacific: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: China: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: China: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Japan: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Japan: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: India: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: India: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: South Korea: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: South Korea: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Australia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Australia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Indonesia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Indonesia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: Europe: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: Europe: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Germany: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Germany: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: France: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: France: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: United Kingdom: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: United Kingdom: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Italy: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Italy: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Spain: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Spain: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Russia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Russia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Latin America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Latin America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Brazil: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Brazil: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Mexico: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Mexico: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: Middle East and Africa: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: Middle East and Africa: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: Global: Cystic Fibrosis Therapeutics Industry: SWOT Analysis
Figure 84: Global: Cystic Fibrosis Therapeutics Industry: Value Chain Analysis
Figure 85: Global: Cystic Fibrosis Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Cystic Fibrosis Therapeutics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2020-2025
Table 3: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Drug Molecule Type (in Million US$), 2020-2025
Table 4: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
Table 5: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 6: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Cystic Fibrosis Therapeutics Market Structure
Table 8: Global: Cystic Fibrosis Therapeutics Market: Key Players